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Abstract
Background: ALG-2 (a gene product of PDCD6) belongs to the penta-EF-hand (PEF) protein family and Ca
2
+-dependently interacts with various intracellular proteins including mammalian Alix, an adaptor protein in the
ESCRT system. Our previous X-ray crystal structural analyses revealed that binding of Ca
2+ to EF3 enables the side
chain of R125 to move enough to make a primary hydrophobic pocket (Pocket 1) accessible to a short fragment of
Alix. The side chain of F122, facing a secondary hydrophobic pocket (Pocket 2), interacts with the Alix peptide. An
alternatively spliced shorter isoform, designated ALG-2
ΔGF122, lacks Gly
121Phe
122 and does not bind Alix, but the
structural basis of the incompetence has remained to be elucidated.
Results: We solved the X-ray crystal structure of the PEF domain of ALG-2
ΔGF122 in the Ca
2+-bound form and
compared it with that of ALG-2. Deletion of the two residues shortened a-helix 5 (a5) and changed the
configuration of the R125 side chain so that it partially blocked Pocket 1. A wall created by the main chain of 121-
GFG-123 and facing the two pockets was destroyed. Surprisingly, however, substitution of F122 with Ala or Gly, but
not with Trp, increased the Alix-binding capacity in binding assays. The F122 substitutions exhibited different
effects on binding of ALG-2 to other known interacting proteins, including TSG101 (Tumor susceptibility gene 101)
and annexin A11. The X-ray crystal structure of the F122A mutant revealed that removal of the bulky F122 side
chain not only created an additional open space in Pocket 2 but also abolished inter-helix interactions with W95
and V98 (present in a4) and that a5 inclined away from a4 to expand Pocket 2, suggesting acquirement of more
appropriate positioning of the interacting residues to accept Alix.
Conclusions: We found that the inability of the two-residue shorter ALG-2 isoform to bind Alix is not due to the
absence of bulky side chain of F122 but due to deformation of a main-chain wall facing pockets 1 and 2.
Moreover, a residue at the position of F122 contributes to target specificity and a smaller side chain is preferable
for Alix binding but not favored to bind annexin A11.
Background
ALG-2 (apoptosis-linked gene 2) is a 22-kDa protein of
191 amino acid residues containing five serially repeti-
tive EF-hand-type helix-loop-helix Ca
2+-binding motifs
(EF1 to EF5) and it belongs to the penta-EF-hand (PEF)
family, including the calpain small subunit, sorcin, gran-
calcin and peflin in mammals [1]. ALG-2 is the most
conserved protein among the PEF family and its homo-
logues are widely found in eukaryotes. Despite the origi-
nal report of a pro-apoptotic function of ALG-2 in T
cell hybridomas [2], ALG-2-deficient mice develop nor-
mally with no obvious abnormalities in the immune sys-
tem [3]. Nonetheless, potential physiological roles of
ALG-2 in control of ER-stress-induced apoptosis, cancer
and cell division have been reported [4-6]. Alix (also
named AIP1) was the first protein identified as an ALG-
2-interacting protein [7,8]. This cytoplasmic 95-kDa
protein is now recognized as an auxiliary factor of the
* Correspondence: mmaki@agr.nagoya-u.ac.jp
1Department of Applied Molecular Biosciences, Graduate School of
Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan
Full list of author information is available at the end of the article
Inuzuka et al. BMC Structural Biology 2010, 10:25
http://www.biomedcentral.com/1472-6807/10/25
© 2010 Inuzuka et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.ESCRT (endosomal sorting complex required for trans-
port) system, which is involved in endosomal sorting,
retrovirus budding and cytokinesis [9-11]. In addition to
roles in the ESCRT system, Alix functions in actin-
cytoskeleton assembly, cell adhesion, signal transduction
and apoptosis [12-15].
X-ray crystal structures of various PEF proteins
including ALG-2 have common features: the presence
of eight a-helices and dimer formation via paired EF5s
that are positioned in anti-parallel orientation [16-20].
Previously, we solved the structures of Ca
2+-free and
-bound forms of N-terminally truncated human ALG-2
(des3-20ALG-2) and a Zn
2+-bound form of full-length
ALG-2 as well as the structure of the complex between
des3-23ALG-2 and the peptide corresponding to
Alix799-814 in the Zn
2+-bound form. Although the
four-EF-hand-region (EF1-EF4) of ALG-2 has a general
structural resemblance to calmodulin, ALG-2 exhibits
o n l yav e r ys m a l lC a
2+-dependent conformational
change. Binding of Ca
2+ (or Zn
2+) to EF3 enables the
side chain of R125, present in the loop connecting EF3
a n dE F 4 ,t om o v ee n o u g ht om a k eap r i m a r yh y d r o -
phobic pocket (Pocket 1) accessible to the critical
PPYP motif found in Alix. This Ca
2+/EF3-driven argi-
nine switch mechanism explains how ALG-2 is acti-
vated by Ca
2+ to bind to its target proteins [21,22].
The C-terminal half of the Alix peptide is also held in
the second hydrophobic pocket (Pocket 2). On the
other hand, in the case of calmodulin, each pair of
EF1-EF2 (N-lobe) and EF3-EF4 (C-lobe) changes its
conformation from “closed” to “open” state upon Ca
2+
binding and exhibits a further gross change in relative
stereotypic position by bending of the central helix
connecting EF2 and EF3 in such a way that the two
lobes grab the targeting peptide [23].
An isoform of ALG-2 was first reported in the mouse
[24]. The isolated cDNA clone designated ALG-2,1 was
shorter in six nucleotides corresponding to the two
amino acids Gly
121Phe
122 in comparison with the full-
length cDNA clone ALG-2,5. Both transcripts were pre-
sent in mouse tissues at an approximate ratio of 2:1
(ALG-2,5 vs ALG-2,1). The same type of isoform lacking
Gly
121 Phe
122 (designated ALG-2
ΔGF122 in this article;
non-deleted ALG-2 being regarded as wild type for con-
venience) is also registered in human DNA databases,
such as GenBank under accession no. BC110291.1.
Interaction of ALG-2
ΔGF122 with Alix is significantly
reduced or not detected in yeast two-hybrid or in vitro
binding assays [24-27]. Although F122 interacts with the
ALG-2-binding site (ABS) peptide of Alix in Pocket 2 in
the crystal structure [21], the molecular basis for the
defect of ALG-2
ΔGF122 in binding to Alix has remained
to be elucidated. In the present study, we crystallized
des3-23ALG-2
ΔGF122 and compared its X-ray crystal
structure with that of the Ca
2+-bound form of des3-
23ALG-2. We found that deletion of the two residues
causes shortening of an a-helix (a5) and leads to a
change in the configuration of the R125 side chain. Sur-
prisingly, however, the F122A mutant (ALG-2
F122A,P h e
substituted with Ala) exhibited an unexpected hyperac-
tivity in Alix-binding. We also investigated effects of
this mutation on the crystal structure, and we discuss
the structural roles of F122 in this article.
Results
Structures of ALG-2
ΔGF122 and ALG-2
F122A
For determination of the 3D structures of ALG-2
ΔGF122
and ALG-2
F122A, we prepared recombinant proteins
with deletion in the N-terminal Gly/Pro-rich region
(des3-23ALG-2
ΔGF122 and des3-20ALG-2
F122A, respec-
tively). Crystal structures we r es o l v e db yt h em o l e c u l a r
replacement method using the previously solved struc-
tures of ALG-2 (PDB IDs 1HQV and 2ZN8) as a search
model. Data collection, processing, and refinement sta-
tistics are summarized in Table 1. The structures of
des3-23ALG-2
ΔGF122 in the Ca
2+-bound form (PDB ID,
3AAJ) and des3-20ALG-2
F122A in the Zn
2+-bound form
(PDB ID, 3AAK) were solved at resolutions of 2.4 Å and
2.7 Å, respectively. Although the obtained data of 3AAK
were processed to 2.5 Å, the refinement gave poor Rwork
and Rfree values (near or greater than 30). Thus, we lim-
ited the resolution to 2.7 Å (Rwork/Rfree, 25.2/29.8). An
asymmetric unit of the crystal of des3-23ALG-2
ΔGF122 in
the Ca
2+-bound form contained two ALG-2 molecules
(A and B) as a dimer (Additional file 1, Figure S1). The
root-mean-square deviation (rmsd) value of the struc-
tures aligned between two molecules was calculated to
be 0.73 Å for C
a atoms from residues L28 to V189. The
structure of molecule A was used for further analysis.
Crystals of the Ca
2+-free and Ca
2+-bound forms of des3-
20ALG-2
F122A suitable for X-ray diffraction were not
obtained.
The basic architectures of the PEF domain containing
eight a-helices (a1-a8), five EF-hand-like helix-loop-
helix motifs (EF1-EF5), and pairing at EF5 as a dimer
were maintained in the solved crystal structures (Figure
1 and Additional file 1, Figure S1), and the overall struc-
tures were very similar when compared with those of
w i l d - t y p eA L G - 2i nt h eC a
2+-bound form of des3-
20ALG-2 (PDB ID 2ZN9) and the Zn
2+-bound form of
full-length ALG-2 (PDB ID 2ZN8), respectively (rmsd
values: des3-23ALG-2
ΔGF122/Ca
2+ vs des3-20ALG/Ca
2+,
1.23 Å for C
a atoms from residues 24-189 of ALG-2;
des3-20ALG
F122A/Zn
2+ vs ALG-2/Zn
2+,0 . 6 2Åf o rC
a
atoms from residues 26-191; des3-20ALG/Ca
2+ vs ALG-
2/Zn
2+,0 . 7 6Åf o rC
a atoms from residues 26-189). In
des3-23ALG-2
ΔGF122, however, the deletion of
Gly
121Phe
122 caused loss of the third turn in a5t h a t
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Page 2 of 14corresponds to the exiting helix of EF3 (Figure 1C,
magenta). The loop connecting a5o fE F 3a n da6o f
EF4 started earlier, but it returned to a similar spatial
position in the middle of the loop around Y122, corre-
sponding to Y124 in wild-type ALG-2 (Figure 2A and
2B). This spatial position of Y122 was supported partly
by hydrogen bonding between the nitrogen atom of
Y122 (N
Y122) and the peptide carbonyl oxygen atom of
L119 (O
L119) and partly by hydrophobic interactions
between C
b of Y122 and C
δ1 of L124 as in the case of
Y124 of wild-type ALG-2 (denoted CB and CD1, respec-
tively, in the Latin alphabet in Table 2). While hydrogen
bonding between the hydroxyl oxygen atom (O
h)o f
Y122 (OH
Y122) and the side chain amide nitrogen atom
(N
ε2)o fQ 1 5 7( N E 2
Q157)i na7w a sn e w l yf o r m e d ,
hydrophobic interactions between side chains of Y122
and L156 were reduced in the ΔGF122 isoform. In the
crystal structure of des3-20ALG-2
F122A in the Zn
2
+-bound form, the axis of a5 inclined slightly outward
from a4a n da7 (see Discussion section) (Figure 1D,
orange).
Configuration of R125 side chain
I nt h ep r e v i o u s l yp r o p o s e dC a
2+/EF3-driven arginine
switch mechanism [21,22], binding of Ca
2+ to EF3
enables formation of a hydrogen bond between one of
the guanidino nitrogen atoms (N
h2)o fR 1 2 5( N H 2
R125)
and the peptide carbonyl oxygen atom of S120 (O
S120),
resulting in change in the configuration of the R125 side
chain (Table 2, Figure 2, A and 2B; Additional file 1,
Figure S2A). Binding of Zn
2+ caused the same effect
(Figure 2C) [21]. In the structure of des3-23ALG-
2
ΔGF122 in the Ca
2+-bound form, however, NH2
R123
(corresponding to NH2
R125 in wild-type ALG-2) did not
form such a hydrogen bond (Figure 2B). The side chain
extended outwardly from the loop as in the case of the
structure of the metal-free form, but the spatial posi-
tions of the side chains between R123 and Y122 were
closer in the equivalent residues in the metal-free ALG-
2 (R125 and Y124) (Additional file 1, Figure S2A). The
lower electron densities corresponding to guanidino
group atoms of R123 suggest flexibility of this side chain
by solvent exposure. On the other hand, NH2
R125 in the
structure of Zn
2+-bound des3-20ALG-2
F122A formed a
hydrogen bond with O
S120, and the side chain of R125
showed a configuration similar to that of wild-type
ALG-2 (Figure 2, C and 2D).
Metal coordination
Three calcium ions were found in EF1, EF3 and EF5 of
des3-23ALG-2
ΔGF122 at the canonical EF-hand coordina-
tion positions (x, y, z, -y, -x and -z), though water mole-
cules at the -x positions in EF1 and EF3 were absent
and no amino acid residue coordinated at the -z posi-
tion in EF5 (Additional file 1, Figure S3; Additional file
2, Table S1). In addition to two zinc ions found in EF1
and EF3 at the canonical coordination positions (Addi-
tional file 2, Table S2), one zinc ion that was
Table 1 Data collection and refinement statistics
des3-23ALG-2
ΔGF122/Ca
2+-bound des3-20ALG-2
F122A/Zn
2+-bound
PDB code 3AAJ 3AAK
Data collection
Beamline PF BL-5A PF AR NW-12
Wavelength (Å)
a 11
Space group P21 C2221
a/b/c (Å)
a 42.6/78.9/60.3 71.3/170.2/47.0
a/b/g (°)
a 90.0/104.6/90.0 90.0/90.0/90.0
Resolution (Å)
a 50.0-2.40(2.49-2.40) 50.0-2.50(2.59-2.50)
Measured reflections 55354 70399
Unique reflections 15185 10302
Completeness (%)
a 97.9(95.1) 97.3(88.4)
Rmerge (%)
a 5.3(18.8) 4.3(12.0)
I/s
a 15.5(5.8) 28.8(14.3)
Refinement
Resolution (Å) 50.0-2.40 50.0-2.70
Rwork/Rfree (%) 19.6/26.6 25.2/29.8
Rmsd bond length (Å) 0.019 0.006
Rmsd bond angle (°) 1.68 0.86
Average B-factor (Å
2) 36.8 56.3
No. ALG-2 molecule 2 1
a Values in parentheses are for highest-resolution shell.
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ΔGF122 and ALG-2
F122A. Structures of (A) Ca
2+-bound des3-23ALG-2
ΔGF122 (PDB ID 3AAJ) and (B) Zn
2+-bound
des3-20ALG-2
F122A (PDB ID 3AAK) are shown in magenta and orange, respectively, in ribbon representations, and EF-hand-coordinated calcium
and zinc ions are shown in gray and light cyan spheres. The deleted site (Gly
121Phe
122) and substituted site (F122A) are marked by an open
arrowhead and closed arrowhead in (A) and (B), respectively. (C, D) The ALG-2 structures are compared with the previously resolved structures of
wild-type ALG-2 of Ca
2+-bound form (PDB ID 2ZN9) and Zn
2+-bound form (PDB ID 2ZN8) by aligning at a-helix 4 (a4), and close-up views of
segments from a5t oa6 are shown in ribbon representations. (C) The structures of Ca
2+-bound des3-20ALG-2 and des3-23ALG-2
ΔGF122 are
shown in green and magenta, respectively. The view in the left panel is rotated approximately 90° to view from the top as shown in the right
panel. (D) The structures of Zn
2+-bound ALG-2 (green) and des3-20ALG-2
F122A (orange) are presented similarly to (C).
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Page 4 of 14coordinated at a non-canonical position was found in
EF5 in the structure of Zn
2+-bound des3-20ALG-2
F122A
(Additional file 1, Figure S4; Additional file 2, Table S3).
In this non-canonical EF-hand coordination, zinc ion
was bonded to OD1
D171 and OD2
D173 in place of
OD1
D169 and O
W175, respectively, at the x and -y posi-
tions. Interestingly, the Ca
2+-bound form and the Zn
2
+-bound form displayed an opposite relationship
regarding the presence of water molecules at -x posi-
tions in wild-type ALG-2 between EF1 and EF3 (water
molecules at -x: EF1/Ca
2+,p r e s e n tvs EF1/Zn
2+,a b s e n t ;
EF3/Ca
2+,a b s e n tvs EF3/Zn
2+, present) (Additional file
2, Table S1; Additional file 2, Table S2). In the Zn
2
+-bound form of ALG-2
F122A, a water molecule was
found at this position in EF1. The difference in ion
radius between calcium and zinc (0.99 Å and 0.74 Å,
Figure 2 Differences in the side chain configurations of R125 and R123. Close-up views of a segment from L115 to D128 (D126 in des3-
23ALG-2
ΔGF122) in each ALG-2 structure are shown in ribbon representations and in stick models superimposed with electron densities of
residues that are involved in the Ca
2+/EF3-driven arginine switch mechanism. The structures of (A, C) wild-type ALG-2, (B) des3-23ALG-2
ΔGF122
and (D) des3-20ALG-2
F122A are colored green, magenta and orange, respectively. R125, a critical residue for the switch mechanism and
interaction with Alix, and its corresponding residue in des3-23ALG-2
ΔGF122 (R123) are colored cyan. The hydrogen bond between the guanidino
nitrogen atom of R125 and carbonyl oxgen atom of S120 is shown by a dotted line and the distance is indicated in (A), (C) and (D).
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nated water molecules at the -x position.
Comparison of surface structures
As shown in Figure 3, the deletion of two residues caused
a noticeable change in the surface structure surrounding
hydrophobic pockets (designated Pocket 1 and Pocket 2),
which were shown to accommodate the Alix ABS peptide
in our previous study [21]. The bottom of Pocket 1 was
supported by Y180 derived from a dimerizing counterpart
molecule of ALG-2 (Figure 3, yellow). A wall formed by
Gly
121Phe
122 in des3-20ALG-2/Ca
2+-bound (Figure 3A,
green) disappeared in des3-23ALG-2
ΔGF122/Ca
2+-bound,
and a surface structure represented by G123 was also
changed (Figure 3B, magenta) The continuous wall formed
by 121-GFG-123 was maintained in Zn
2+-bound des3-
20ALG-2
F122A (Figure 3D, orange: Gly
121Ala
122; magenta,
G123). The R125 side chain (Figure 3, cyan) was oriented
away from Pocket 1 in the metal-bound ALG-2 proteins
(Figure 3, A, C and 3D). On the other hand, the side chain
directed toward Pocket 1 in Ca
2+-bound des3-23ALG-
2
ΔGF122 (Figure 3B), but it did not fully block the entry
path of Pocket 1 as in the case of metal-free ALG-2 (Addi-
tional file 1, Figure S2B).
Effects of amino acid substitutions of F122 on binding
capacities and specificities
To investigate whether the side chain of F122 influences
association between ALG-2 and Alix, we performed
real-time surface plasmon resonance (SPR) interaction
analyses using purified recombinant full-length ALG-2
and F122-substituted mutants as well as ALG-2
ΔGF122 as
analytes and an Alix ABS peptide as a ligand. The reso-
nance signals at 10 s before the dissociation phase were
compared with that of wild-type (WT) ALG-2 and
expressed as relative binding capacities (Additional file
1, Figure S5). Higher binding capacities were observed
for the ALG-2 mutants of F122A (240%) and F122G
(140%), whereas lower binding capacities were observed
for ALG-2
ΔGF122 (18%) and the mutants of F122W
(36%) and F122S (89%).
Next, we investigated whether substitutions of
F122 equally influence binding to endogenous ALG-2-
interacting proteins by pulldown assays using
glutathione-S-transferase (GST)-fused ALG-2 proteins
and unfused GST as a negative control (Ctrl) (Figure 4).
Pulldown products were analyzed by Western blotting
with specific antibodies against Alix, TSG101, Sec31A,
annexin A7 and annexin A11. GST-ALG-2
ΔGF122 gave
essentially no specific immunoreactive signals except for
Sec31A. For Alix interaction, the mutants of small side
chain substitutions (F122G, F122A and F122S) gave
stronger signals than those of WT and F122W mutant.
Compared to the results obtained by SPR analyses (Addi-
tional file 1, Figure S5), GST-pulldown assays gave much
more enhanced signals for mutants than for WT. Even
F122W mutant gave a capacity similar to that of WT.
Capacities of ALG-2 binding to TSG101 and Sec31A
were not different from WT in all F122 mutants. Com-
pared to WT, only F122A mutant gave significantly stron-
ger signals for annexin A7, whereas signals for annexin
A11 were decreased in all mutants.
Augmentation of staurosporine-induced cell death by
expression of ALG-2
F122A
Staurosporine, a microbial alkaloid, acts as a non-selective
protein kinase inhibitor with high potency by binding to
ATP-binding pockets of kinases [28], and it induces cell
death via caspase-dependent and -independent apoptotic
pathways [29]. Previously, Vito et al. reported that ALG-2
and Alix (named AIP1 in the article) modulate staurospor-
ine-induced cell death [8]. To investigate whether the
enhanced Alix-binding capacity by F122A mutant exerts
augmentation of cell death, we employed previously
Table 2 Intramolecular interactions of ALG-2 in Ca
2+/EF3-
driven arginine switching loop
WT ΔGF122
interacting atom MF
a Ca
b Ca
c
S120
Hydrogen Distance (Å)
NO
K116 2.8 3.2 3.1
ON
G123/121 2.8 2.8 ND
d
NH2
R125/123 ND 2.8 ND
OG O
L116 2.6 ND ND
Y124/122
hydrogen
NO
L119 3.1 3.0 3.0
OH NE2
Q159/157 ND ND 2.8
hydrophobic
CB C
L119 ND 3.9 ND
CD1
L126/124 3.9 3.7 3.9
CG
L126/124 ND ND 3.7
CD1 CB
F122/- 3.7 3.6 -
e
CD1
L158/156 ND ND 4.0
CD2 CD2
L158/156 3.9 ND ND
CE1 CB
F122/- 3.8 3.8 -
CD1
F122/- 3.9 ND -
CD2
L158/156 3.9 ND ND
CE2 CG
L158/156 3.5 ND ND
CD2
L158/156 3.7 3.8 ND
CZ CD1
L158/156 ND 4.0 ND
a Metal-free form of des3-20ALG-2
b Ca
2+-bound form of des3-20ALG-2
c Ca
2+-bound form of des3-23ALG-2
ΔGF122
d Not detected in the range of 2.6-3.2 Å for hydrogen bonding and 3.2-4.0 Å
for hydrophobic interaction
e Not present in des3-23 ALG-2
ΔGF122
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Page 6 of 14established ALG-2-knockdown (ALG-2KD) HeLa cells
whose endogenous ALG-2 level was reduced by the RNA
interference (RNAi) method [26]. After transfection with
RNAi-resistant expression plasmids of either wild-type or
mutant ALG-2 proteins or with a vector as a control, cells
were treated with staurosporine for 24 h. The degree of
cell death was estimated by measuring the amounts of lac-
tate dehydrogenase (LDH) released into the culture med-
ium. As shown in Figure 5, cells not treated with
staurosporine released small amounts of LDH under
the conditions used (closed columns, 6-8% of total LDH
activities). On the other hand, dramatic increases
were observed for the release of LDH from staurosporine-
treated cells in all cases tested (open columns, 29-46%),
but vector-transfected ALG-2KD HeLa cells (29%) showed
lower values than vector-transfected parental HeLa cells
(36%). The amounts of released LDH were increased
slightly by exogenous expressions of wild-type (WT) ALG-
2 (36%) and ALG-2
ΔGF122 (33%) in ALG-2KD HeLa cells.
The augmentation was statistically significant (P < 0.01)
when ALG-2
F122A was exogenously expressed (46%)
and compared with the vector-transfected ALG-2KD HeLa
cells (29%).
Discussion
A variant of ALG-2 cDNA lacking six nucleotides is
found in human DNA databases. Since Gly
121Phe
122 is
i m m e d i a t e l yf o l l o w e db yG l yi nt h ea m i n oa c i d
Figure 3 Loss of a wall surrounding hydrophobic pockets in ALG-2
ΔGF122. Surface structures of (A) Ca
2+-bound des3-20ALG-2, (B) Ca
2
+-bound des3-23ALG-2
ΔGF122, (C) Zn
2+-bound ALG-2, and (D) Zn
2+-bound des3-20ALG-2
F122A are presented in gray except for indicated residues
of Gly
121Phe
122 (green), G123 (or G121 in des3-23ALG-2
ΔGF122) (magenta), A122 in the F122A mutant (orange), R125 (or R123 in des3-23ALG-
2
ΔGF122) (cyan), Y180 (or Y178 of des3-23ALG-2
ΔGF122) from a dimerized counterpart molecule (yellow).
Inuzuka et al. BMC Structural Biology 2010, 10:25
http://www.biomedcentral.com/1472-6807/10/25
Page 7 of 14sequence, the deletion of Phe
122Gly
123 is assigned in the
results of BLAST searches using the blastp or tblastn
program. In the nucleotide sequence of cDNAs, how-
ever, the deletion occurs in GGTTTC (Gly
121Phe
122) but
not in TTCGGC (Phe
122Gly
123) in the sequence of
TCAGGTTTCGGCTAC (corresponding to 120-SGFGY-
124). In the current human EST database, the ratio of
retrieved human ALG-2 cDNAs containing nucleotides
corresponding to Gly
121Phe
122 and those lacking the
corresponding hexanucleotides is approximately 3:1. In
this article, we designate the major ALG-2 isoform as
wild type (WT) to discriminate it from the shorter and
minor isoform. Analysis of the human genome database
revealed that the ALG-2 gene (symbol, PDCD6; location,
5 pter-p15.2) has six exons and that the boundary
sequence of Exon 4 and Intron 4 contains an alternative
splicing donor site (TCAGGTTTCGgtaactcactcactc:
lower case, intron sequence; boldfaced sequence, miss-
ing by alternative splicing). The alternatively spliced
ALG-2 isoform, designated ALG-2
ΔGF122,i sd e f e c t i v ei n
Alix-binding [24-26]. These two residues (Gly
121Phe
122)
comprise the last turn in a5 in the crystal structures
[18,21]. However, the structural basis for the inability of
ALG-2
ΔGF122 to bind Alix has remained to be estab-
lished. In the present study, we investigated the role of
Gly
121Phe
122 by solving the X-ray crystal structure of
the shorter isoform and by mutational analyses of F122.
Comparison of the crystal structures of des3-20ALG-2
and des3-23ALG-2
ΔGF122 in the Ca
2+-bound forms
revealed a significant difference in spatial positions of
residues adjacent to Gly
121Phe
122 (Figures 1, 2, 3). Since
S120 is located within a5 in ALG-2 but is placed at the
end of the truncated helix in ALG-2
ΔGF122 (Figure 1), an
a-helix-supporting hydrogen bond between O
S120 and
N
G121 (G123 in wild type) is disrupted (Table 2). This
causes a change in the spatial orientation of O
S120,a n d
the hydrogen bond with NH2
R125 in wild-type ALG-2 is
lost in NH2
R123 in ALG-2
ΔGF122. Then, the side chain
of R123 is placed to partially block Pocket 1, which is
a primary acceptor site for the Alix ABS peptide
(Figures 2 and 3) and resembles the topology of R125 in
the Ca
2+-unbound (metal-free) form of wild-type ALG-2
(Additional file 1, Figure S2). F122, present in a5( e x i t -
ing a-helix of EF3), interacts with residues W95 and
V98 in a4( e n t e r i n ga-helix of EF3) and stabilizes the
EF-hand motif in metal-free des3-20ALG-2 (Table 3
and Additional file 1, Figure S2C,). This inter-helix
interaction is maintained partly in the Ca
2+-bound form
(F122-V98 interaction) and disrupted in Ca
2+-bound
Figure 4 Effects of amino acid substitutions of F122 on binding
specificities. ALG-2-interacting proteins in HEK293 cells were pulled
down with GST-fused ALG-2 of wild type (WT), ALG-2
ΔGF122 (ΔGF122),
and F122-substituted mutants. Unfused GST was used as a negative
control (Ctrl). Proteins bound to glutathione Sepharose beads were
subjected to Western blotting with antibodies against Alix, TSG101,
Sec31A, annexin A7, and annexin A11.
Figure 5 Augmentation of staurosporine-induced cell death by
ALG-2
F122A. Parental (Prnt) HeLa cells and ALG-2-knockdown (ALG-
2KD) HeLa cells were transfected with a vector (pcDNA3) as controls.
ALG-2KD cells were transfected with plasmids that express wild-type
ALG-2, ALG-2
ΔGF122 or ALG-2
F122A and cultured for 24 h. The
transfected cells were treated with 1 μM staurosporine for 24 h. Cell
death was monitored by measuring the amounts of lactate
dehydrogenase (LDH) released into the culture medium as
described in Materials and Methods. Total amounts of LDH released
into the medium and retained in cells were expressed as 100%.
Duplicate assays of five independent repetitive experiments were
performed and data are presented as means +/- SD (n = 5). Closed
column, not treated with staurosporine; open column, treated with
staurosporine. Statistically significant differences among
staurosporine-treated cells were evaluated by Student’s t-test by
comparing the measured values of samples with those of control
ALG-2KD cells that were transfected with a control vector (*, P <
0.05; **, P < 0.01)
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ΔGF122 d u et ot h ea b s e n c eo fF 1 2 2( F i g u r e6 ,A
and 6B, Table 3). The distance between the C
a atoms of
Y122 and T160 (facing Pocket 1) is shorter in the crystal
structure of des3-23ALG-2
ΔGF122 (Figure 6B, 8.7 Å) than
that between the corresponding Y124 and T162 in the
Ca
2+-bound (Figure 6A, 9.9 Å) and metal-free structure
of des3-20ALG-2 (Additional file 1, Figure S2C, 9.0 Å),
indicating a narrower Pocket 1 in the isoform. More-
over, the main chain of G123 in wild-type ALG-2
(Figure 3, magenta) is placed to face Pocket 1, and the
main chain carbonyl carbon (C’) interacts hydrophobi-
cally with the Alix ABS peptide [21], but this interaction
is no longer possible because a continuous wall formed
by Gly
121Phe
122 ( f a c i n gP o c k e t2 )a n dG 1 2 3( f a c i n g
Pocket 1) is destroyed in ALG-2
ΔGF122 (Figure 3).
Our previous X-ray crystal structure analyses of the
complex between ALG-2 and the Alix ABS peptide (1-
QGPPYPTYPGYPGYSQ-16, core motif boldfaced)
revealed that an aromatic moiety of F122, constituting
Pocket 2, interacts hydrophobically with Y11 of the Alix
ABS peptide [21]. Surprisingly, however, substitution of
F122 with Ala or Gly did not abolish the binding but
instead increased the binding capacities as shown by
SPR analyses, and substitution with Trp caused a
decrease in the binding capacity (Additional file 1,
Figure S5). Similar effects were observed by GST-pull-
down assays of endogenous Alix (Figure 4). Thus, it is
thought that the inability of ALG-2
ΔGF122 to bind Alix is
not due to the absence of a residue with a large hydro-
phobic side chain at residue No. 122 but is due to the
unfavorable topology of the loop connecting a5a n da6
caused by deletion of the two residues. This idea may
also explain the finding by Subramanian et al. that a sin-
gle amino acid deletion of F122 caused a marked
decrease in Alix-binding capacity [30]. On the other
hand, the presence of an aromatic bulky side chain at
this position (in Pocket 2) may be rather detrimental for
binding to Alix due to steric hindrance. Interestingly,
substitution of either M71 or Q159 (both present in
Pocket 2 and interacting with the Alix ABS peptide in
the complex crystal structure) with Ala resulted in
higher Alix-binding capacities [21]. Thus, more open
space or a deeper trough in Pocket 2 seems to favor
interactions with Alix. The F122S mutant showed lower
binding capacity (89%) than that of wild-type ALG-2 by
SPR analyses (Additional file 1, Figure S5), but the GST-
ALG-2
F122S mutant exhibited a higher capacity than that
of the wild type in the GST-pulldown assay. This discre-
pancy may arise from the differences in the ligands to
be assayed (SPR: ABS oligopeptide corresponding to
residue No. 799-814 of Alix; GST-pulldown: endogenous
Alix protein of 868 residues) because residues 815-842
also contribute to interactions with ALG-2 to some
extent [31].
EF-hand proteins have similar helix-loop-helix struc-
tures, but conformational states with respect to angles
and distances between the two helices and their changes
in response to Ca
2+ binding are very diverse [32]. Unlike
calmodulin, ALG-2 does not exhibit a significant change
from the closed conformational state in the absence of
Ca
2+ to the open conformational state in the presence
Ca
2+ [21]. Nevertheless, binding of Ca
2+ or Zn
2+ to EF3
causes a small shift of a5 and leads to change in config-
uration of the R125 side chain [21]. Substitution of F122
with Ala disrupts the inter-helix interaction between a4
and a5 (Figure 6, C and 6D). Comparison of the esti-
mated angles formed by a4 (entering helix) and a5
(exiting helix) in EF3 between the structures of wild-
type ALG-2 (θ = 54.5°) and des3-20ALG-2
F122A (θ =
62.6°) in the Zn
2+-bound forms (Table 4) indicates incli-
nation of a5b y8 . 1 °a w a yf r o ma4, resulting in a shift
in the position of the C
a atom of F122A for 2.0 Å
(Figure 1D). This more open conformation of the EF-
hand motif in F122A mutant maintains distances or
causes a small increase in distances between the C
a
atoms of Y124 and T162 (facing Pocket 1) (WT, 9.9 Å;
F122A, 10.1 Å) and between the C
a atoms of F122/
A122 and Q159 (facing Pocket 2) (WT, 10.2 Å; F122A,
Table 3 Loss of intramolecular interactions in F122A
mutant
WT F122A
interacting atom MF
a Ca
b Zn
c Zn
d
Distance (Å)
F122 A122
hydrogen
NO
A118 ND 2.9 3.2 ND
e
O
L119 3.0 3.1 ND 3.2
hydrophobic
CB CD1
Y124 3.7 3.6 3.9 ND
CE1
Y124 3.8 3.8 4.0 ND
CD1 C
A118 ND ND 4.0 -
f
CA
L119 3.9 ND 4.0 -
CD2
L119 3.9 3.7 4.0 -
CE1
Y124 3.9 ND ND -
CE1 CH2
W95 3.9 ND ND -
CZ3
W95 3.9 ND ND -
CE2 CG1
V98 ND 4.0 ND -
CZ CH2
W95 3.9 ND ND -
CZ3
W95 3.5 ND 3.9 -
CG1
V98 3.8 3.5 3.6 -
a Metal-free form of des3-20ALG-2
b Ca
2+-bound form of des3-20ALG-2
c Zn
2+-bound form of ALG-2
d Zn
2+-bound form of des3-20ALG-2
F122A
e Not detected in the range of 2.6-3.2 Å for hydrogen bonding and 3.2-4.0 Å
for hydrophobic interaction
f Not present in des3-20ALG-2
F122A
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Page 9 of 14Figure 6 Close-up views of structural interrelations among a4, a5 and a7. Residues influencing space size in the hydrophobic pockets are
shown in stick models and described in Discussion. Thick dotted lines represent hydrophobic interactions. Thin dotted lines indicate C
a-
distances that show differences in the pockets between wild-type and mutant ALG-2 structures. In the stick model representation, carbons
atoms are colored in blue for W95 and V98, green for F122, orange for A122 and gray for Y124, Q159 and T162.
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Page 10 of 1410.7 Å). On the other hand, regardless of the disruption
of inter-helix interaction, ALG-2
ΔGF122 gave only a small
increase in the angle (WT, θ = 57.6°; ΔGF122, θ = 58.6°)
in the Ca
2+-bound form structure (Table 4), and the dis-
tance between the C
a atoms of Y124 and T160 was sig-
nificantly decreased in ALG-2
ΔGF122 (Figure 6, WT, 9.9
Å; ΔGF122, 8.7 Å). Consequently, the change in the
relative spatial positions of a5 and the following loop
may allow the side chains of A122, Y124 and adjacent
R 1 2 5t op l a c ea tm o r ea p p r o p r i a t ep o s i t i o n si nt h e
hydrophobic pockets of ALG-2
F122A to interact with the
Alix ABS peptide. To corroborate the above hypothetical
mechanism of enhanced binding of ALG-2
F122A to Alix,
we attempted co-crystallization of des3-20ALG-2
F122A
with the Alix ABS peptide but could not obtain good
crystals. The nature of N-terminal residues of ALG-2
influences qualities of crystals. In the present study, we
used des3-20ALG-2
F122A because X-ray diffraction reso-
lutions were better in des3-20ALG-2 (2.4 Å) than in
des3-23ALG-2 (3.1 Å) in the Ca
2+-bound forms in our
previous study [33]. It would be worthwhile, however, to
test des3-23ALG-2
F122A for crystal preparations of the
complex.
ALG-2 interacts with various proteins with Pro-rich
regions [34]. Previously, we classified ALG-2-interacting
proteins into two groups (Alix type and non-Alix type)
based on ability of binding to ALG-2
ΔGF122 [27]. Alix-
type proteins such as TSG101, annexin A7 and annexin
A11 contain a consensus sequence of PPYPX3-5YP
(where X is uncharged residues and PPYP is substituta-
ble with PXYP or XPYP) similar to the core motif of
Alix [21]. On the other hand, ALG-2
ΔGF122 retains bind-
ing ability to non-Alix-type proteins such as Sec31A and
phospholipid scramblase 3 (PLSCR3) that possess a
common sequence of PXPGF (where X is P or A) but
whose indispensability remains to be experimentally ver-
ified [26,27]. The mutation of F122 had different effects
on capacities of binding to endogenous proteins among
Alix-type proteins, even to two paralogous annexin
family proteins (Figure 4). Although ALG-2-binding
sites still remain to be identified, annexin A7 and
annexin A11 have 4-PGYPPTGYPP-13 and 4-
PGYPPPPGGYPP-15, respectively. A clear difference
between the two sequences is the number of residues
present between two YPs (annexin A7, 3 vs annexin
A11, 5). Since F122 constitutes Pocket 2 and interacts
with the aromatic side chain of the corresponding sec-
ond YP in the Alix ABS peptide, mutation of F122
seems favored or disfavored for interaction depending
on spatial positions of the concerned Tyr residues in the
target proteins. Recently, mucolipin-1 has been shown
to Ca
2+-dependently interact with ALG-2 but not with
ALG-2
ΔGF122 [35]. The predicted binding site (37-
EEDLRRRLKYFF-49) does not contain any YP or
PXPGF motif, but charged residues as well as hydropho-
bic residues were shown to be important for interac-
tions. Thus, mucolipin-1 may be recognized by a surface
different from that for binding to Pro-rich target pro-
teins. Ask1 and Raf-1, which are also known to interact
with ALG-2 [36,37], do not possess conspicuous Pro-
rich regions either, and the ALG-2-binding site has not
been reported yet. It would be interesting to see whether
F122A and other amino acid-substituted mutants of
Pocket 1 and Pocket 2 present a different binding profile
between Pro-rich type and non-Pro-rich type ALG-2-
interacting proteins.
The biological significance of the occurrence of ALG-
2
ΔGF122 is not known. ALG-2 forms a dimer and each
molecule of the dimer has capacity of Alix binding [21].
Recently, we demonstrated that ALG-2 (a longer iso-
form, wild type) functions as a Ca
2+-dependent adaptor
protein that bridges Alix and TSG101, whereas ALG-
2
ΔGF122, retaining dimerization ability, does not have
such a function toward Alix and TSG101 [38]. Occur-
rence of ALG-2
ΔGF122 in the cell should give chances to
form dimers in different combinations at different ratios
according to the expressed levels of wild-type ALG-2
and ALG-2
ΔGF122 (WT/WT, WT/ΔGF122, ΔGF122/
ΔGF122). Although ALG-2 dimers of WT/ΔGF122 and
ΔGF122/ΔGF122 are inactive adaptors at least for the
Alix-type ALG-2-interacting proteins, the WT/ΔGF122
dimer may still function for non-Alix-type proteins.
Although the molecular mechanism of the ALG-2 func-
tion in staurosporine-induced cell death is not known
yet, slight augmentation of staurosporine-induced cell
death by ALG-2
ΔGF122 (Figure 5) suggests that non-Alix
type ALG-2-interacting proteins are also involved.
Recent clinical investigations suggest that ALG-2 is a
potential prognostic marker of certain lung and gastric
Table 4 Angles and distances calculated for ALG-2 EF3.
ALG-2 EF3 has a4 (entering helix, residue No. 93-102)
and a5 (exiting helix, residue No. 112-122), but a
segment of a5 (residue No. 112-120, common to ALG-
2
ΔGF122) was used
Angle (°) Distance (Å)
θ  ω inner ends midpoint outer ends
WT MF
a 49.5 104 137 10.6 12.2 14.7
Ca
b 57.6 96.9 131 10.7 12.7 15.6
Zn
c 54.5 98.0 130 10.7 12.6 15.4
ΔGF122 Ca
d 58.6 88.8 134 10.7 13.1 16.3
F122A Zn
e 62.6 97.6 128 11.0 13.2 16.4
a Metal-free form of des3-20ALG-2
b Ca
2+-bound form of des3-20ALG-2
c Zn
2+-bound form of ALG-2
d Ca
2+-bound form of des3-23ALG-2
ΔGF122
e Zn
2+-bound form of des3-20ALG-2
F122A
Angles and distances were estimated by the Vector Geometry Mapping (VGM)
software (Ref. 50)
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Page 11 of 14cancers [39,40]. Expression analyses of ALG-2 by further
distinguishing alternatively spliced isoforms would pro-
vide more reliable data in clinical studies. RBM22, a
highly conserved RNA-binding protein functioning as an
auxiliary factor of the spliceosome, was shown to inter-
act with ALG-2 [41]. It would be interesting to see
whether ALG-2 regulates its own splicing as well as Ca
2
+-dependent alternative splicing events [42]. Future stu-
dies are needed to clarify whether ALG-2
ΔGF122 plays
roles merely as a negative inhibitor of wild-type ALG-2
or positively functions by associating with ALG-2
ΔGF122-
specific interacting proteins.
Conclusions
Structural basis of the inability of the splicing isoform of
human ALG-2, ALG-2
ΔGF122, to bind to Alix was inves-
tigated by X-ray crystal structural analysis. Missing of
two residues, Gly
121Phe
122, causes shortening of an a-
helix (a5) and leads to a change in the configuration of
the R125 side chain that resembles that of the metal-
free form of ALG-2. Contrary to the expected impor-
tance of bulky side chain of F122, the F122A mutant
exhibited a surprising hyperactivity in binding to Alix.
The resolved structure of the F122A mutant showed
that removal of the bulky F122 side chain not only cre-
ated an additional open space in Pocket 2 but also abol-
ished inter-helix interactions with W95 and V98
(present in a4) and that a5 inclined away from a4t o
expand Pocket 2, suggesting acquirement of more
appropriate positioning of the interacting residues to
accept Alix. However, no hyperactivity against TSG101
or annexin A11 suggests that F122 partly restricts the
recognition specificity to target proteins.
Methods
Bacterial expression and purification of recombinant ALG-
2 proteins
Bacterial expressions of untagged ALG-2 by the T7
RNA polymerase system and GST-fused protein by
pGEX vector were described previously [25,43]. Con-
struction of the expression plasmid for an alternatively
spliced ALG-2 isoform that lacks Gly
121Phe
122 (desig-
nated ALG-2
ΔGF122) and GST-ALG-2
ΔGF122 was
described previously [25]. Single amino acid substitution
mutation of ALG-2 was performed according to the
instruction manual provided with a QuikChange Site-
Directed Mutagenesis kit (Stratagene, USA) using speci-
fic oligonucleotide primers listed in Additional file 2,
Table S4. Recombinant ALG-2 proteins of wild type and
mutants (ALG-2, ALG-2
ΔGF122,A L G - 2
F122A,A L G -
2
F122G,A L G - 2
F122S,A L G - 2
F122W, des3-23ALG-2
ΔGF122,
des3-20ALG-2
F122A) were purified by affinity chromato-
graphy using a column immobilizing an ALG-2-binding
site-2 (ABS-2) peptide of PLSCR3 as described
previously [27]. GST fusion proteins were expressed and
purified with glutathione Sepharose beads (GE Health-
care) according to the manufacturer’s instructions.
Crystallization
Purified proteins were concentrated to about 10 mg/ml
with a vacuum centrifuge evaporator (Sakuma, Japan).
Concentrated proteins were dialyzed against 10 mM
Tris-HCl, pH 7.5, containing 10 μMe a c ho fE D T Aa n d
EGTA. Crystallization conditions were first screened
with an automated robotic system [44] and further opti-
mized manually. Crystals were grown by the sitting or
hanging drop vapor diffusion method at 20°C. Des3-
23ALG-2
ΔGF122 protein was crystallized with 25% (w/v)
PEG-4000, 50 mM sodium cacodylate, pH 6.0, 300 mM
ammonium acetate, and 10 mM calcium chloride. Des3-
20ALG-2
F122A protein was crystallized with 25% (w/v)
2-methyl-2,4-pentanediol (MPD), 100 mM sodium caco-
dylate, pH 6.5, and 50 mM zinc acetate.
Data collection, structure determination, refinement, and
analyses
X-ray diffraction data were collected at beamlines BL-5A
and NW-12 of Photon Factory (Tsukuba, Japan) under
cryogenic conditions with crystals soaked in a cryopro-
tectant solution containing 20% glycerol and cooled to
100 K in a nitrogen gas stream. The diffraction data
were integrated and scaled with the HKL2000 program
package [45]. Crystal structures were solved by the
molecular replacement method using the program
MOLREP [46] with the published structure of ALG-2
(PDB ID 1HQV and 2ZN8) as a search model for des3-
23ALG-2
ΔGF122 and des3-20ALG-2
F122A. All models
were refined with the programs CNS [47] and
REFMAC5 in the CCP4 package [48]. Manual adjust-
ments of the model were performed with COOT [49].
All of the structural figures were generated with PyMol
(DeLano Scientific LLC, Palo Alto, CA). Rmsd was cal-
culated with the program lsqkab in the CCP4 package
[48]. Inter-helix angles and distances of EF-hand motifs
were estimated by using vector geometry mapping
(VGM) software [50] downloaded from URL: http://cal-
cium.uhnres.utoronto.ca/vgm/.
Binding assays
Real-time binding analyses were performed using an SPR
biosensor (Biacore2000, GE Healthcare) at 25°C. A syn-
thetic peptide of the ALG-2-binding site in Alix
(kggsggsQGPPYPTYPGYPGYSQ, lower case residues
indicating a linker, provided by Biosynthesis Inc., USA)
was immobilized on the carboxymethylated dextran sur-
face of a CM5 sensor chip (GE Healthcare) as described
previously [21]. For interaction analyses, flow rate was
maintained at 20 μl/min. Purified ALG-2 and mutants
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pH 7.4, 150 mM NaCl, 0.005% surfactant P20) containing
100 μMC a C l 2 and then injected and kept flowing over the
immobilized sensor surface for 180 s. The sensor surface
was then washed for 300 s with the same buffer and regen-
erated with the buffer containing 1 mM EGTA.
GST-pulldown assays of ALG-2 and its mutants were
performed using cleared lysates of HEK293 cells as
described previously [40]. Proteins bound to the beads
(pulldown products) were analyzed by Western blotting
using specific antibodies. Mouse monoclonal antibody
(mAb) of anti-annexin VII (A-1) and goat polyclonal anti-
body (pAb) of anti-annexin XI (N-17) were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-TSG101
mAb (4A10) and Sec31A mAb (clone32) were from Gene
Tex (San Antonio, TX) and BD Transduction Laboratories
(San Diego, CA), respectively. Preparation of anti-Alix
pAb was described previously [25]. Signals of Western
blotting were detected by the chemiluminescence method
and analyzed with LAS-3000mini (Fujifilm, Japan).
Cell culture, DNA transfection and cell death assays
Constructs of pcDNA3/ALG-2/RNAi
R and pcDNA3/
ALG-2
ΔGF122/RNAi
R that express RNAi-resistant ALG-2
mRNAs were obtained by transferring EcoRI/XhoIf r a g -
ments to the pcDNA3 vector from their previously con-
structed expression vectors of FLAG-tagged versions [37].
Construction of pcDNA3/ALG-2
F122A/RNAi
R was per-
formed by site-directed mutagenesis using pcDNA3/ALG-
2/RNAi
R as a template and the primers (F122A) listed in
Additional file 2, Table S4. An ALG-2 knockdown HeLa
cell line was established by expression of the short hairpin
RNA specific for ALG-2 mRNA as described previously
[25]. One day after the cells had been seeded, they were
transfected with the expression plasmid DNAs by using
FuGENE6 (Roche, Basel, Switzerland). After 24 h, aliquots
of cell suspensions (each 0.5 ml) were transferred to a 24-
well plate, incubated for 24 h, and then treated with or
without 1 μM staurosporine for 24 h. Cell mortality was
measured by quantifying the amount of lactate dehydro-
genase (LDH) released from dead cells using the Cyto-
Tox96® Non-Radioactive Cytotoxicity Assay (Promega,
USA) according to the manufacturer’s instructions. Total
amount of LDH per sample (released and retained
enzymes in dead and viable cells) was measured by lysing
cells in 0.5 ml culture by adding the provided 10× Lysis
buffer containing 9% Triton X-100.
Additional material
Additional file 1: Supplementary figures. Showing structures of the
calcium-bound dimeric form of des3-23ALG-2
ΔGF122 (Figure S1), the
metal-free form of des3-20ALG-2 (Figure S2), EF-hand Ca
2+-coordination
in des3-23ALG-2
ΔGF122 (Figure S3), non-canonical Zn
2+-coordination in
EF5 (Figure S4), and SPR analyses of F122 mutants of ALG-2 for Alix-
binding capacities (Figure S5).
Additional file 2: Supplementary tables. Showing bond distances for
the canonical EF-hand metal ion coordinates in ALG-2 for calcium (Table
S1) and zinc (Table S2), bond distance for the non-canonical zinc ion
coordinate in EF5 (Table S3), and primers used for site-directed
mutagenesis performed in this study (Table S4).
List of abbreviations
ABS: ALG-2-binding site; LDH: lactate dehydrogenase; PEF: penta-EF-hand;
RNAi: RNA interference; SPR: surface plasmon resonance; TSG101: tumor
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